Fig. 7From: Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cellsImmunofluorescence showed the expression of RIPK3 and MLKL in OVCAR3 cells. OVCAR3 cells were treated with BBR (100 μM) and/or DDP (5 mg/L) for 24 h. The expression levels and subcellular localization of RIPK3 (a) and MLKL (b) were detected by immunofluorescence assay. Data were based on at least three independent experimentsBack to article page